3-HYDROXY-5-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 5g

4-(4,4-DIFLUOROPIPERIDIN-1-YL)-3,5-DIFLUOROANILINE, 95.0%, 1g

HPTLC Plates ALUGRAM® Xtra Nano-SIL G with Nano Silica Gel, 5 x 20 cm, 50 Piece(s)

N-(4-Bromo-3-methylphenyl)acetamide, 95.0%, 5g

3-Cyano-2-fluorophenylboronic Acid (contains varying amounts of Anhydride)1g

(S)-2-(1-Methoxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

Chenodeoxycholic acid, 95.0%, 500g

(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one, 96%, 50mg

(1S,4S)-ETHYL 4-((TERT-BUTYLDIMETHYLSILYL)OXY)CYCLOHEXANECARBOXYLATE, 95.0%, 250mg

Sample vials ROTILABO® with short thread ND9 silanised, Clear glass, with solid conical base, 1.1 ml, 100 Piece(s)

2-(2-Chloropyrimidin-4-yl)propan-2-ol, 100mg

6-Bromoisatin, 97.0%, 25g

4-Ethoxy-3-methoxyphenylacetic acid, 95.0%, 5g